7,474 Shares in Cardinal Health, Inc. $CAH Purchased by Trail Ridge Investment Advisors LLC

Trail Ridge Investment Advisors LLC bought a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 7,474 shares of the company’s stock, valued at approximately $1,776,000. Cardinal Health comprises approximately 0.8% of Trail Ridge Investment Advisors LLC’s investment portfolio, making the stock its 24th biggest position.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. BlackRock Inc. purchased a new stake in shares of Cardinal Health during the second quarter worth about $6,293,115,000. Norges Bank purchased a new position in shares of Cardinal Health during the fourth quarter valued at approximately $790,344,000. Wellington Management Group LLP lifted its stake in shares of Cardinal Health by 153.2% during the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock valued at $911,010,000 after buying an additional 3,511,579 shares during the period. Bank of New York Mellon Corp acquired a new stake in Cardinal Health during the second quarter worth approximately $308,640,000. Finally, Deutsche Bank AG acquired a new stake in Cardinal Health during the second quarter worth approximately $238,933,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.1%

NYSE:CAH opened at $232.13 on Tuesday. The company has a market cap of $53.99 billion, a P/E ratio of 32.11, a P/E/G ratio of 1.23 and a beta of 0.49. Cardinal Health, Inc. has a fifty-two week low of $145.87 and a fifty-two week high of $258.30. The firm’s 50 day moving average is $232.13 and its two-hundred day moving average is $217.96.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. Cardinal Health’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Research analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be given a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Insider Activity

In other news, insider Jessica L. Mayer sold 29,436 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the transaction, the insider directly owned 33,076 shares of the company’s stock, valued at $7,812,220.44. The trade was a 47.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Michelle D. Greene sold 11,650 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.72, for a total value of $2,746,138.00. Following the sale, the insider owned 10,330 shares of the company’s stock, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 210,271 shares of company stock valued at $49,626,657 in the last 90 days. 0.12% of the stock is owned by corporate insiders.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Wall Street Analyst Weigh In

Several research analysts have weighed in on CAH shares. Citigroup boosted their price target on Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 4th. Barclays lifted their price objective on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th. Bank of America upped their target price on Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday, July 2nd. Finally, Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $266.56.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.